Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Smoking Cessation 3Tobacco Use Cessation 1Pain 1Neoplasms 1Agnosia 1

Interventions

Dexamethasone 12Bevacizumab 9Saline Solution 8Bupivacaine 8Tobacco Use Cessation Devices 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 7Rituximab 6Prednisone 6Letrozole 6Lenalidomide 6Fluorouracil 6Cisplatin 6Carboplatin 6pembrolizumab 5Sodium Chloride 5Ropivacaine 5Human Papillomavirus Recombinant Vaccine nonavalent 5Trastuzumab 4Tamoxifen 4Standard of Care 4Propofol 4Paclitaxel 4Immune Checkpoint Inhibitors 4Esomeprazole 4Enoxaparin 4Doxorubicin 4Bortezomib 4Bismuth 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Varenicline × 1 year × Clear all
NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
204 enrolled

Smoking Cessation, Tobacco Use Cessation

NCT06218823 2025-10-27

Tobacco Treatment Comparison for Cancer Care

University of Wisconsin, Madison

Phase 4 Completed
52 enrolled 9 charts

Neoplasms, Smoking Cessation

NCT06029907 2025-09-04

Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.

Duke University

Phase 4 Completed
19 enrolled

Agnosia, Pain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡